The science of stroke: mechanisms in search of treatments

Author(s): Moskowitz MA, Lo EH, Iadecola C

Abstract

This review focuses on mechanisms and emerging concepts that drive the science of stroke in a therapeutic direction. Once considered exclusively a disorder of blood vessels, growing evidence has led to the realization that the biological processes underlying stroke are driven by the interaction of neurons, glia, vascular cells, and matrix components, which actively participate in mechanisms of tissue injury and repair. As new targets are identified, new opportunities emerge that build on an appreciation of acute cellular events acting in a broader context of ongoing destructive, protective, and reparative processes. The burden of disease is great, and its magnitude widens as a role for blood vessels and stroke in vascular and nonvascular dementias becomes more clearly established. This review then poses a number of fundamental questions, the answers to which may generate new directions for research and possibly new treatments that could reduce the impact of this enormous economic and societal burden.

Similar Articles

Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry

Author(s): Reeves MJ, Arora S, Broderick JP, Frankel M, Heinrich JP, et al.

Thrombolytic therapy for ischemic stroke--a review

Author(s): Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, et al.

Thrombolytic therapy for ischemic stroke--a review

Author(s): Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, et al.

Newer thrombolytic agents

Author(s): Verstraete M

Thrombolysis with alteplase 3 to 4

Author(s): Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, et al.

Oxytosis: A novel form of programmed cell death

Author(s): Tan S, Schubert D, Maher P

A broadly neuroprotective derivative of curcumin

Author(s): Liu Y, Dargusch R, Maher P, Schubert D

Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer's disease

Author(s): Valera E, Dargusch R, Maher PA, Schubert D

Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance

Author(s): Panzhinskiy E, Hua Y, Lapchak PA, Topchiy E, Lehmann TE, et al.

Suppressive effects of a pyrazole derivative of curcumin on airway inflammation and remodeling

Author(s): Narumoto O, Matsuo Y, Sakaguchi M, Shoji S, Yamashita N, et al.

Neurovascular injury in acute hyperglycemia and diabetes: A comparative analysis in experimental stroke

Author(s): Elgebaly MM, Ogbi S, Li W, Mezzetti EM, Prakash R, et al.

A broadly neuroprotective derivative of curcumin

Author(s): Liu Y, Dargusch R, Maher P, Schubert D

2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo

Author(s): Liot G, Benchenane K, Léveillé F, López-Atalaya JP, Fernández-Monreal M, et al.

Acceleration of thrombolysis with ultrasound through the cranium in a flow model

Author(s): Spengos K, Behrens S, Daffertshofer M, Dempfle CE, Hennerici M

A call for transparent reporting to optimize the predictive value of preclinical research

Author(s): Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, et al.